Home / Inspections / 1003899

FDA Inspection 1003899 — Syntho Pharmaceuticals, Inc.

Syntho Pharmaceuticals, Inc. — FEI 3003407422

The FDA completed an inspection of Syntho Pharmaceuticals, Inc. on March 9, 2017 in Farmingdale, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 9, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmingdale, NY (United States)

Facility

Other inspections at this facility

  • 1101047 (OAI Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 984108 (OAI Fri Aug 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 844933 (OAI Fri Aug 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 768857 (OAI Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 754919 (OAI Mon Nov 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources